Perennial Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Perennial Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2014-11-19FDA Approved: FEXOFENADINE HYDROCHLORIDE — Original Application (7-eleven)
FDA approved a generic version of fexofenadine hydrochloride (ANDA 202039) for allergic rhinitis and chronic urticaria, with 7-eleven as the…
-
FDA approval · 2014-11-18FDA Approved: CHILDREN ALLERGY — Original Application (Walgreens)
FDA approved Walgreens' original application for a pediatric allergy product containing fexofenadine hydrochloride (Children Allergy).
-
CLINICAL_TRIALS trial_result · 2014-10-21Clinical Trial Update: The Role of Montelukast in Rhinitis and Sleep [Phase 4]
Phase 4 clinical trial evaluated montelukast for perennial allergic rhinitis and sleep outcomes; results were posted in 2014. The study was …
-
CLINICAL_TRIALS trial_result · 2014-09-29Clinical Trial Update: Study of the Safety and Pharmacokinetics of Montelukast (MK-0476) in the Treatment of Japanese Pediatric Participants With Perennial Allergic Rhinitis (MK-0476-520) [Phase 3]
Phase 3 clinical trial studying the safety and pharmacokinetics of montelukast in Japanese children with perennial allergic rhinitis has com…
-
CLINICAL_TRIALS trial_result · 2014-09-12Clinical Trial Update: Postmarketing Surveillance to Investigate the Safety and Efficacy Information of Alesion® Tablet
A completed postmarketing surveillance study evaluating the safety and efficacy information of Alesion® Tablet in perennial allergic rhiniti…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2014-09-11FDA Approved: MONTELUKAST — Original Application (BluePoint Laboratories)
FDA approved Montelukast from BluePoint Laboratories under an Original Application (ANDA), granting generic montelukast access for approved …
-
CLINICAL_TRIALS trial_result · 2014-08-27Clinical Trial Update: A Comparator Study of Fluticasone Propionate Nasal Spray Verses (vs) Cetirizine in the Treatment of Seasonal Allergic Rhinitis [Phase 4]
Phase 4 trial comparing Fluticasone propionate nasal spray to cetirizine for seasonal allergic rhinitis, with results posted after completio…
-
CLINICAL_TRIALS trial_result · 2014-08-15Clinical Trial Update: A Study of the Efficacy and Safety of Desloratadine (MK-4117) in Japanese Participants With Perennial Allergic Rhinitis (MK-4117-200) [Phase 3]
Phase 3 trial evaluating the efficacy and safety of desloratadine (MK-4117) in Japanese participants with perennial allergic rhinitis has co…
-
CLINICAL_TRIALS trial_result · 2014-07-24Clinical Trial Update: A 6 Month Safety Study Of Ciclesonide Nasal Aerosol (Zetonna®) And Ciclesonide Nasal Spray (Omnaris®) In Subjects 12 Years And Older With Perennial Allergic Rhinitis (PAR) [Phase 4]
Phase 4 safety study evaluating 6 months of ciclesonide nasal aerosol (Zetonna) and ciclesonide nasal spray (Omnaris) in subjects aged 12 ye…
-
CLINICAL_TRIALS trial_result · 2014-07-16Clinical Trial Update: NasoNeb Delivery of an Intranasal Steroid [Phase 4]
Phase 4 trial results update for NasoNeb-delivered intranasal steroid in perennial allergic rhinitis.
-
CLINICAL_TRIALS trial_result · 2014-07-14Clinical Trial Update: Epinastine + Pseudoephedrine SR (Slow Release) Versus Epinastine Alone in Patients With Perennial Allergic Rhinitis [Phase 3]
A Phase 3 trial comparing epinastine with sustained-release pseudoephedrine versus epinastine alone in patients with perennial allergic rhin…
-
CLINICAL_TRIALS trial_result · 2014-07-14Clinical Trial Update: WAL801CL (Epinastine Hydrochloride) Dry Syrup in Paediatric Perennial Allergic Rhinitis [Phase 3]
A Phase 3 clinical trial evaluating WAL801CL (epinastine hydrochloride) dry syrup in pediatric perennial allergic rhinitis has completed.
-
FDA approval · 2014-06-12FDA Approved: NASACORT ALLERGY 24HR — Supplemental Application (Chattem, Inc.)
FDA approved a supplemental application for NASACORT ALLERGY 24HR (triamcinolone acetonide) submitted by Chattem, Inc.
-
FDA approval · 2014-06-02FDA Approved: DYMISTA — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for DYMISTA (azelastine hydrochloride and fluticasone propionate) by Viatris Specialty LLC. The appr…
-
CLINICAL_TRIALS trial_result · 2014-05-26Clinical Trial Update: Safety Study of the Potential Inhibitory Effects of Ciclesonide Nasal Aerosol on the Hypothalamic-Pituitary-Adrenal Axis in Subjects 6-11 Years With Perennial Allergic Rhinitis [Phase 3]
Phase 3 safety trial evaluating whether intranasal ciclesonide affects the hypothalamic-pituitary-adrenal axis in children aged 6-11 with pe…
-
CLINICAL_TRIALS trial_result · 2014-05-23Clinical Trial Update: Development of Cockroach Immunotherapy by the Inner-City Asthma Consortium [Phase 1]
A Phase 1 trial evaluating cockroach allergen immunotherapy for asthma and perennial allergic rhinitis has completed, with results posted in…
-
CLINICAL_TRIALS trial_result · 2014-05-06Clinical Trial Update: A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR). [Phase 3]
Phase 3 trial assessing safety and efficacy of ciclesonide nasal aerosol in children 6-11 with perennial allergic rhinitis; results from the…
-
CLINICAL_TRIALS trial_result · 2014-04-15Clinical Trial Update: Effectiveness of Beclomethasone Dipropionate Nasal Aerosol for Perennial Allergic Rhinitis
Completed clinical trial assessing the effectiveness of Beclomethasone Dipropionate Nasal Aerosol for perennial allergic rhinitis.
-
CLINICAL_TRIALS trial_result · 2014-04-09Clinical Trial Update: Probiotic Administration and Perennial Allergic Rhinitis [NA]
The clinical trial evaluating probiotic administration for perennial allergic rhinitis has completed.
-
FDA approval · 2014-04-07FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for montelukast sodium from Torrent Pharmaceuticals Limited, granting generic approval under ANDA 20…
-
CLINICAL_TRIALS trial_result · 2013-12-16Clinical Trial Update: Efficacy and Safety of Levocetirizine Versus Loratadine for the Treatment of Perennial Allergic Rhinitis [Phase 3]
A Phase 3 trial comparing levocetirizine with loratadine for perennial allergic rhinitis has completed, assessing efficacy and safety.
-
FDA approval · 2013-10-18FDA Approved: ALLEGRA-D ALLERGY AND CONGESTION — Supplemental Application (Chattem, Inc.)
FDA approved a supplemental application for Allegra-D Allergy and Congestion, the combo of fexofenadine hydrochloride and pseudoephedrine hy…
-
CLINICAL_TRIALS trial_result · 2013-10-16Clinical Trial Update: Safety, Efficacy and Pharmacokinetic Study of Allegra in Pediatric Patients With Perennial Allergic Rhinitis (PAR) [Phase 2, Phase 3]
A pediatric safety, efficacy, and pharmacokinetic study of Allegra (fexofenadine) in children with perennial allergic rhinitis has completed…
-
FDA approval · 2013-09-04FDA Approved: CAREONE ALLERGY RELIEF — Supplemental Application (American Sales Company)
FDA approved a supplemental application for CAREONE ALLERGY RELIEF (fexofenadine HCl) from American Sales Company; this pertains to the supp…
-
CLINICAL_TRIALS trial_result · 2013-08-27Clinical Trial Update: Efficacy and Safety of Mometasone Furoate Plus Azelastine HCl Combination Versus Mometasone Furoate Alone or Azelastine Alone in Patients With Perennial Allergic Rhinitis [Phase 3]
A Phase 3 trial assessed the efficacy and safety of a mometasone furoate plus azelastine HCl nasal combination versus mometasone furoate alo…